Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 4 examiners • 0 of 6 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
L.E.A.F. Holdings Group LLC currently has 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 3 distinct examiners across 3 distinct art units. SHOMER, ISAAC is the busiest examiner for the company, overseeing 2 pending office actions. The distribution of 5 pending actions among 3 examiners indicates that some examiners are managing multiple cases, with the busiest handling 2 of the active matters. The use of 3 distinct art units shows that the company's biotech filings are spread across several technical groups.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (17%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 4 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHOMER, ISAAC | 2 | 63.1% | +30.5% |
| CABRAL, ROBERT S | 2 | 62.8% | +32.3% |
| PACKARD, BENJAMIN J | 1 | 66.9% | +15.3% |
| JARRELL, NOBLE E | 1 | 80.9% | +10.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018132 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | PACKARD, BENJAMIN J | 36d overdue |
| 19018165 | ALPHA POLYGLUTAMATED LOMETREXOL AND USES THEREOF | SHOMER, ISAAC | — |
| 18968387 | GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF | SHOMER, ISAAC | — |
| 17917910 | METHODS OF SYNTHESIZING CAROTENOIDS | JARRELL, NOBLE E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018132 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | PACKARD, BENJAMIN J | 36d overdue |
| 19018165 | ALPHA POLYGLUTAMATED LOMETREXOL AND USES THEREOF | SHOMER, ISAAC | — |
| 19016832 | ALPHA POLYGLUTAMATED PRALATREXATE AND USES THEREOF | CABRAL, ROBERT S | — |
| 18968387 | GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF | SHOMER, ISAAC | — |
| 18755082 | ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF | CABRAL, ROBERT S | — |
| 17917910 | METHODS OF SYNTHESIZING CAROTENOIDS | JARRELL, NOBLE E | — |
| Art Unit | Apps |
|---|---|
| 1612 | 3 |
| 1614 | 2 |
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19018165 | ALPHA POLYGLUTAMATED LOMETREXOL AND USES THEREOF | SHOMER, ISAAC | 1612 | §102§112Other | Non-Final OA | — | Pending | Jan 13, 2025 |
| 19016832 | ALPHA POLYGLUTAMATED PRALATREXATE AND USES THEREOF | CABRAL, ROBERT S | 1614 | §112DP | Non-Final OA | — | Pending | Jan 10, 2025 |
| 18968387 | GAMMA POLYGLUTAMATED RALTITREXED AND USES THEREOF | SHOMER, ISAAC | 1612 | §102§112Other | Non-Final OA | — | Pending | Dec 04, 2024 |
| 18755082 | ALPHA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF | CABRAL, ROBERT S | 1614 | DP | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18018132 | TRANS-CROCETIN COMPOSITIONS AND TREATMENT REGIMENS | PACKARD, BENJAMIN J | 1612 | §103§112 | Final Rejection | 36d overdue | Pending | Jan 26, 2023 |
| 17917910 | METHODS OF SYNTHESIZING CAROTENOIDS | JARRELL, NOBLE E | 1699 | §102§112 | Non-Final OA | — | Pending | Oct 07, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialL.E.A.F. Holdings Group LLC has 6 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Isaac Shomer has the most, with 2 of L.E.A.F. Holdings Group LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
